Patient Leaflet Updated 23-Jun-2025 | Ipsen Ltd
Salvacyl
Salvacyl
11.25 mg powder and solvent for prolonged-release suspension for injection
Triptorelin
What is in this leaflet:
1. What Salvacyl is and what it is used for
2. What you need to know before you use Salvacyl
3. How to use Salvacyl
4. Possible side effects
5. How to store Salvacyl
6. Contents of the pack and other information
Salvacyl contains triptorelin, which is similar to a hormone called gonadotropin releasing hormone (GnRH analogue). It is a long acting formulation designed to slowly deliver 11.25 mg of triptorelin over twelve weeks. It acts by lowering the levels of the male hormone, testosterone, in the body.
Salvacyl is used to decrease sexual drive in adult men with severe sexual deviations.
The treatment with Salvacyl is to be initiated and controlled by a psychiatrist. The treatment should be given in combination with psychotherapy, in order to decrease deviating sexual behaviour.
At the beginning of treatment there will be an increased amount of testosterone in your body. This might result in an increase in sexual drive. Your doctor may give you some medicine (an anti-androgen) to counteract this effect.
Talk to your doctor:
When the treatment is stopped, testosterone will return to normal levels and your sexual drive may increase again. Therefore your doctor may give you another medicine in order to control this effect.
Salvacyl is not indicated for use in neonates, infants, children and adolescents.
When Salvacyl is taken with medicines which affect the release of hormones from the pituitary (part of the brain), your doctor may need to do additional checks.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Salvacyl might interfere with some medicines used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone and sotalol) or might increase the risk of heart rhythm problems when used with some other drugs (e.g. methadone (used for pain relief and part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics used for serious mental illnesses).
Salvacyl is not to be used by women.
You may feel dizzy, tired or have problems with your sight such as blurred vision. These are possible side effects of treatment. If you experience any of these side effects you should not drive or use machines.
This medicinal product contains sodium but less than 1 mmol (23 mg) sodium per vial. This medicine is almost ‘sodium-free’ and may be taken with a low sodium diet.
Salvacyl is prepared by and is always given to you by a doctor or nurse.
The usual dose is 11.25 mg (one vial) of Salvacyl, given as a single injection into a muscle every twelve weeks.
If you think the effect of Salvacyl is too strong or too weak, contact your doctor.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Many of the side effects are expected, due to the change in the level of testosterone in your body. These effects include hot flushes and impotence.
In rare cases (may affect up to 1 in 1,000 people) you may experience a severe allergic reaction and commonly (may affect up to 1 in 10 people) you may experience an allergic reaction. Stop taking Salvacyl and contact a doctor or go to your nearest emergency department immediately if you experience any of the following symptoms: swallowing or breathing problems, swelling of your lips, face, throat or tongue, or a rash.
Very common: may affect more than 1 in 10 people:
Common: may affect up to 1 in 10 people:
Uncommon: may affect up to 1 in 100 people:
Rare: may affect up to 1 in 1,000 people:
Not known: frequency cannot be estimated from the available data
An increase in white blood cell count may be found, as with other GnRH analogues, in patients being treated with Salvacyl.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, vial and ampoule after ‘EXP’. The expiry date refers to the last day of that month.
Do not store above 25° C.
Chemical and physical in-use stability has been demonstrated for 24 hours at 25°C. From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is triptorelin.
One vial of powder contains 11.25 mg of triptorelin, as triptorelin embonate.
Reconstituted suspension (2 ml) contains 11.25 mg of triptorelin, as triptorelin embonate.
The other ingredients are:
Powder: poly (d, l-lactide-co-glycolide), mannitol, carmellose sodium and polysorbate 80.
Solvent: water for injection.
Salvacyl is a white to off-white powder.
The solvent is a clear solution.
The package contains:
1 vial with powder
1 ampoule with 2 ml of solvent
1 injection syringe
2 needles.
Marketing Authorisation Holder
Manufacturer
This medicinal product is authorised in the Member States of the EEA under the following names: Sweden: Moapar 11.25 mg
Belgium, Germany, Denmark, Finland, Netherlands, United Kingdom, Austria, Ireland and Poland: Salvacyl 11.25 mg
France: Salvacyl LP
Norway and Greece: Salvapar
Is this leaflet hard to see or read? Please phone +44 (0) 1753 627777 and ask for help.
This leaflet was last revised in January 2025
5th Floor, The Point, 37 North Wharf Road, London, W2 1AF, UK
+44 (0)1753 627 777
+44 (0)1753 627 627